Crossmark

Identification of Clinical and Laboratory Variables Associated with Cardiotoxicity Events Due to Doxorubicin in Breast Cancer Patients: A 1-Year Follow-Up Study

Crossref DOI link: https://doi.org/10.1007/s12012-020-09600-7

Published Online: 2020-08-25

Published Print: 2021-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Simões, Ricardo

Silva, Luciana Maria

de Oliveira, Angélica Navarro

Alves, Michelle Teodoro

Pestana, Rodrigo Mendonça Cardoso

de Souza, Isabella Dâmaris Passos

Oliveira, Heloísa Helena Marques

Soares, Cintia Esteves

Sabino, Adriano de Paula

Gomes, Karina Braga https://orcid.org/0000-0002-6870-2063
Funding

Funding for this research was provided by:

FAPEMIG

CNPq
License Information

Text and Data Mining valid from 2020-08-25

Version of Record valid from 2020-08-25
More Information

Article History

Received: 9 April 2020

Accepted: 14 August 2020

First Online: 25 August 2020

Compliance with Ethical Standards

:

: All authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below